Accelerating time from result to clinical action: impact of an automated critical results reporting system

Articles in the same Issue

1. Frontmatter
2. Editorials
3. Challenging the dogma: why reviewers should be allowed to use AI tools
4. Multivariate approaches to improve the interpretation of laboratory data
5. Review
6. Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic review
7. Opinion Papers
8. Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics
9. The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference
10. Supplementation of pyridoxal-5′-phosphate in aminotransferase reagents: a matter of patient safety
11. HCV serology: an unfinished agenda
12. From metabolic profiles to clinical interpretation: multivariate approaches to population-based and personalized reference intervals and reference change values
13. Genetics and Molecular Diagnostics
14. A multiplex allele specific PCR capillary electrophoresis (mASPCR-CE) assay for simultaneously analysis of SMN1/SMN2/NAIP copy number and SMN1 loss-of-function variants
15. General Clinical Chemistry and Laboratory Medicine
16. From assessment to action: experience from a quality improvement initiative integrating indicator evaluation and adverse event analysis in a clinical laboratory
17. Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis
18. Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
19. The current status of serum insulin measurements and the need for standardization
20. Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
21. Cerebrospinal fluid leptin in Alzheimer’s disease: relationship to plasma levels and to cerebrospinal amyloid
22. Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences
23. An innovative immunoassay for accurate aldosterone quantification: overcoming low-level inaccuracy and renal dysfunction-associated interference
24. Oral salt loading combined with postural stimulation tests for confirming and subtyping primary aldosteronism
25. Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis
26. Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels
27. Reference Values and Biological Variations
28. Establishment of region-, age- and sex-specific reference intervals for aldosterone and renin with sandwich chemiluminescence immunoassays
29. Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
30. Comparative analysis of population-based and personalized reference intervals for biochemical markers in peri-menopausal women: population from the PALM cohort study
31. Hematology and Coagulation
32. Evaluation of stability and potential interference on the α-thalassaemia early eluting peak and immunochromatographic strip test for α-thalassaemia --^SEA carrier screening
33. Cardiovascular Diseases
34. Analytical and clinical evaluation of an automated high-sensitivity cardiac troponin I assay for whole blood
35. Diabetes
36. Method comparison of diabetes mellitus associated autoantibodies in serum specimens
37. Letters to the Editor
38. Permitting disclosed AI assistance in peer review: parity, confidentiality, and recognition
39. Response to the editorial by Karl Lackner
40. Hemolysis detection using the GEM 7000 at the point of care in a pediatric hospital setting: does it affect outcomes?
41. Estimation of measurement uncertainty for free drug concentrations using ultrafiltration
42. Cryoglobulin pre-analysis over the weekend
43. Accelerating time from result to clinical action: impact of an automated critical results reporting system
44. Recent decline in patient serum folate test levels using Roche Diagnostics Folate III assay
45. Kidney stones consisting of 1-methyluric acid
46. Congress Abstracts
47. 7th EFLM Conference on Preanalytical Phase
48. Association of Clinical Biochemists in Ireland Annual Conference
49. Association of Clinical Biochemists in Ireland Annual Conference
50. 16th Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine